NCT07675837Not yet recruiting
Inducible Co-stimulator Gene With Systemic Lupus Erythematosus
Association of ICOS Gene Polymorphism With Susceptibility and Severity of Systemic Lupus Erythematosus.
Source: ClinicalTrials.gov · Last updated 30 Jun 2026
Brief summary (registry, in English)
The aim of this study is to investigate the association between ICOS gene polymorphism and susceptibility to systemic lupus erythematosus (SLE), as well as its impact on disease severity.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 23 Jun 2026
- Start date
- Jun 2026
- Primary completion date
- Jun 2027
- Lead sponsor
- South Valley University
- Diseases
- Lupus (SLE)
- NCT number
- NCT07675837
What you commit to
- Study type: Observational
- Planned participants: 30
- From Jun 2026 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other autoimmune diseases or chronic inflammatory disorders. Malignancy. Pregnancy or breastfeeding. Inability to provide informed consent.
Who the study is looking for
- Patients diagnosed with SLE based on 2019 EULAR/ACR Male or female. willing to provide written informed consent for participation and genetic testing
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| South Valley University Hospital Coordinator of this site? Confirm its status | Qina | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.